RecruitingNCT05681572
Midazolam, dexmedetomidine or placebo before children’s general anesthesia
About this title
Read the official source — NCT05681572Medication studyAges 7–18FranceAnxiety
Understand this study
Who could participate?
Listed age limits: 7 years to 18 years.
- Listed locations
- MontpellierSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: April 18, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 1,000
- Sponsor
- University Hospital, Montpellier
- Sponsor type
- Hospital / academic medical center
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- France
- Age range
- From 7 Years to 18 Years
- Official registry ID
- NCT05681572
- Official title
Show the full official title
" Effect of Sedative and Anxiolytic Premedication on Children Experience After General Anesthesia " The pediaPREM Study.
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Montpellier
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University Hospital, Montpellier, a hospital or academic medical center.
Does this study involve medication?
Yes. The study involves medication, including Midazolam, Dexmedetomidine and Placebo.
Who can participate?
Listed age limits: 7 years to 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
